Laura Chambers retweeted
From poo to promise: Fecal microbiota transplants support immunotherapy resensitization in solid tumors
@LAURAJMOULTON @SciBehindSciPod @dspakowicz highlight work showing FMT improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers cell.com/cell-host-micr…
@LAURAJMOULTON @SciBehindSciPod @dspakowicz highlight work showing FMT improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers cell.com/cell-host-micr…
0
16
46
4,176
Laura Chambers retweeted
Had a great time the other evening with my incredible partnersat @OSUCCC_James - @FBackesMD and @LAURAJMOULTON discussing the incredible advances in our care of patients with gynecological malignancies @OncLive #SOSS
0
1
17
597
Laura Chambers retweeted
Excited to have many clinical trial opportunities for our patients and proud to be leading accrual for GOG foundation trials nationally @OSUCCC_James @osugynonc #NRG2024 #GOGF #GOGPARTNERS
0
1
12
512
Excited to share our work about impact of antibiotics and PPI on endometrial
cancer patients @dspakowicz @omalleygynonc @OSUCCC_James
cancer patients @dspakowicz @omalleygynonc @OSUCCC_James
Impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
1
3
7
1,949
Laura Chambers retweeted
#Editorial The inclusion of patient perspectives & timely management of toxicity in these guidelines should be applauded 👏 👏
By @mollyymorton
🔗 bit.ly/3P0VNe1
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert @IJGCfellows
By @mollyymorton
🔗 bit.ly/3P0VNe1
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert @IJGCfellows
0
5
21
1,608
Laura Chambers retweeted
Type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer @mollyymorton @LAURAJMOULTON @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…
0
5
10
1,666
Laura Chambers retweeted
Thanks @gynoncjnls for helping us share our work! @LAURAJMOULTON
Prevalence of type 2 diabetes diagnoses in the perioperative and survi... sciencedirect.com/science/articl…
Prevalence of type 2 diabetes diagnoses in the perioperative and survi... sciencedirect.com/science/articl…
0
3
4
686
Laura Chambers retweeted
Thank you to @greenjrnl, @LAURAJMOULTON for supporting this project - clinical trials improve outcomes for our patients!
pubmed.ncbi.nlm.nih.gov/37535957/
pubmed.ncbi.nlm.nih.gov/37535957/
0
3
10
750
Laura Chambers retweeted
A labor of love (and physiology) with @LAURAJMOULTON @OSUCCC_James
Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer sciencedirect.com/science/articl…
Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer sciencedirect.com/science/articl…
1
5
17
1,512
Proud of this important work by @MollyMorton17 @OSUCCC_James
“More than a song and dance”: Exploration of patient perspectives and ... sciencedirect.com/science/articl…
“More than a song and dance”: Exploration of patient perspectives and ... sciencedirect.com/science/articl…
0
4
10
1,619
Laura Chambers retweeted
The modified 5-item frailty index is a predictor of post-operative complications in #VulvarCancer @LAURAJMOULTON @kbixelMD
🔗bit.ly/3KpW9Z8
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
🔗bit.ly/3KpW9Z8
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
0
6
11
2,379
Laura Chambers retweeted
Excellent presentation by Dr Molly Morton on the importance of clinical trials. Trial patients do better and live longer. @SGO_org #swedishcancerinstitute
0
5
18
929
Excellent opening session presentation by @osugynonc fellow @MollyMorton17 on improved OS with clinical trial participation in platinum resistant OC @SGO_org @CleObGynTracks
0
3
21
687
Laura Chambers retweeted
AddThis | Home authors.elsevier.com/sd/article/S00…
Now part of NCCN guidelines for PROC. Earlier opportunity to gain access for patients in patients with PSOC (GOG 3078; GLORIOSA). @OSUCCC_James @GOG.
Now part of NCCN guidelines for PROC. Earlier opportunity to gain access for patients in patients with PSOC (GOG 3078; GLORIOSA). @OSUCCC_James @GOG.
0
4
9
1,307
Dr O'Malley @omalleygynonc discussing the exciting GOG/NRG portfolio on ovarian cancer clinical trials @NRGonc @OSUCCC_James
0
0
10
474
My amazing partner @kbixelMD giving updates on ROCC trial @leitaomd @OSUCCC_James @osugynonc @NRGonc @omalleygynonc
0
2
19
1,425
Join me in attending The GOG Foundation, Inc. Dinner Meeting on Thursday, January 26th from 6:30 pm – 9:30 pm ET. For more information on this event for participating sites, go to gog.org/event/the-gog-……. #clinicaltrials #GynecologicOncology #GOGPartners #GOGF
@GOG
@NRGonc
@GOG
@NRGonc
0
0
3
330
Laura Chambers retweeted
An intact #microbiome functions as a tumor suppressor in #OvarianCancer, and antibiotics perturb gut microbiota to promote tumor growth and suppress cisplatin sensitivity.
bit.ly/3O1Kr8s
@oreizes @LAURAJMOULTON @OSUWexMed
bit.ly/3O1Kr8s
@oreizes @LAURAJMOULTON @OSUWexMed
0
5
6
Thrilled to share our work supporting that disruption of the #gutmicrobiome impacts platinum chemotherapy response in #ovariancancer just published in @CR_AACR. Such an important, collaborative effort @oreizes @ChadMichenerMD @RobertoVargasMD @CCLRI.
Advanced release of our manuscript “Disruption of the gut microbiota … pubmed.ncbi.nlm.nih.gov/36206317/ is now online. Great collaboration with @ChadMichenerMD @LAURAJMOULTON @JustinLathia @claesengroup @RobertoVargasMD and many more @CCLRI @ClevelandClinic @caseccc
1
3
14
Chambers-Spakowicz @dspakowicz labs seek a motivated postdoc to join a team studying the microbiome and chemo/IO treatment responses in gynecologic cancers at the @OhioStatePIIO and @OSUCCC_James! @osugynonc go.osu.edu/microbiome-pos…
0
2
5